Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

Status:
Completed

Trial end date:
2020-11-17

Target enrollment:

Participant gender:

This study will assess the safety and efficacy of ARQ-151 cream vs placebo applied once a day for 56 days by subjects with chronic plaque psoriasis

Phase 3

Arcutis Biotherapeutics, Inc.